Octreotide Diacetate is a synthetic somatostatin analog used to treat acromegaly, carcinoid syndrome, and tumors secreting vasoactive intestinal peptide by inhibiting the release of various hormones and… Read more
Octreotide Diacetate is a synthetic somatostatin analog used to treat acromegaly, carcinoid syndrome, and tumors secreting vasoactive intestinal peptide by inhibiting the release of various hormones and neurotransmitters. This category provides essential reference standards, including the active pharmaceutical ingredient, its related impurities, and metabolites. Pharmaceutical laboratories utilize these high-quality compounds for critical analytical testing, such as method validation, impurity profiling, and rigorous quality control protocols. The inclusion of stable isotope labelled compounds, such as octreotide acetate D8, allows for accurate quantification and identification during complex mass spectrometry studies. By maintaining access to these specialized materials, researchers can ensure compliance with regulatory standards and maintain consistency throughout the pharmaceutical development process for this important peptide medication.